Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Institut de Cancérologie Neuwirth |
Principal Investigator: |
Olivier Collard, Dr |
|---|---|
Contact: |
Olivier COLLARD, Dr 00 334 77 91 70 34 olivier.collard@icloire.fr |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Institut de Cancérologie Neuwirth Website: |
http://etablissements.fhf.fr/annuaire/hopital-fiche.php?id_struct=4731 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.